Scalability is a common issue facing pharma leaders who have deployed Generative AI (GenAI) applications as a proof of concept (PoC). Many are dazzled by their promise of streamlining staid work processes. Agentic AI and other new GenAI technologies can make PoCs faster and easier to launch, advancing scalability as well as security and development… The post Scaling pharma AI PoCs to enterprise deployments: Blending new tech with old-school rigor appeared first on Drug Discovery and Develop...
